Multiple Myeloma

by in

Entry	Blogger	Date	Location
Acceleron, Bucking Conventional Wisdom, Pushes Ahead Drug For Bone Loss, Anemia	Luke Timmerman	09/11/09	Boston
$252M Potential in CLDA and CombinatoRx Deal	Ryan McBride	08/13/09	Boston
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner	Ryan McBride	08/07/09	Boston
Genzyme’s Mozobil Gets European Approval	Ryan McBride	08/05/09	Boston
Genzyme Wins FDA Approval of Mozobil	Luke Timmerman	12/15/08	Boston
Blood News: A Quick Rundown of Headlines From the American Society of Hematology	Luke Timmerman	12/09/08	National
Millennium’s Velcade, As Time Wears On, Shows Durable Ability to Prolong Lives	Luke Timmerman	12/08/08	Boston
Biogen Turns Down Dying Patient’s Request For Tysabri—and Explains Why	Luke Timmerman	10/14/08	Boston
Biogen Idec, Elan Start First Cancer Trial With Tysabri	Luke Timmerman	09/05/08	Boston
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.